S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94

AdAlta Stock Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume135,957 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

Receive 1AD News and Ratings via Email

Sign-up to receive the latest news and ratings for AdAlta and its competitors with MarketBeat's FREE daily newsletter.

About AdAlta

AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein therapeutics in Australia. The company's lead i-body drug candidate includes AD-214, which is in Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. It has a collaborative partnership with GE Healthcare to discover i-bodies against granzyme B for use as a molecular imaging agent. AdAlta Limited was incorporated in 2006 and is based in Bundoora, Australia.


See More Headlines

Industry, Sector and Symbol

Year Founded

Sales & Book Value

Annual Sales
$3.98 million
Book Value
A$0.03 per share





Next Earnings Date
Not Optionable


Overall MarketRank

0.88 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

AdAlta (ASX:1AD) Frequently Asked Questions

What stocks does MarketBeat like better than AdAlta?

Wall Street analysts have given AdAlta a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but AdAlta wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are AdAlta's key executives?

AdAlta's management team includes the following people:
  • Dr. Timothy Charles Oldham B.Sc., L.L.B., BSc(Hons), LLB(Hons), Ph.D., CEO, MD & Director
  • Dr. Dallas Hartman, Chief Operating Officer
  • Prof. Michael Foley Ph.D., Chief Scientific Advisor & Chief Scientific Officer
  • Mr. Cameron Jones C.A., Company Sec.

What other stocks do shareholders of AdAlta own?

What is AdAlta's stock symbol?

AdAlta trades on the ASX under the ticker symbol "1AD."

How much money does AdAlta make?

AdAlta has a market capitalization of $0.00 and generates $3.98 million in revenue each year.

What is AdAlta's official website?

The official website for AdAlta is www.adalta.com.au.

How can I contact AdAlta?

The company can be reached via phone at 61 3 9479 5159.

This page was last updated on 10/16/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.